U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Animal & Veterinary
  3. Development & Approval Process
  4. Biotechnology Products at CVM: Animals and Animal Food
  5. Cell and Tissue Products for Animals
  6. Clinical Field Studies for Animal Cells, Tissues, and Cell- and Tissue-Based Products (ACTPs)
  1. Cell and Tissue Products for Animals

Clinical Field Studies for Animal Cells, Tissues, and Cell- and Tissue-Based Products (ACTPs)

This page is a resource that provides animal owners, veterinarians, researchers, and the public with access to information on clinical field studies investigating the use of ACTPs in veterinary patients. A clinical field study is a research study in which animals are enrolled based on a study plan and are evaluated for effects of biomedical or health outcomes. Enrolled animals may be pets (dogs, cats, etc.) or production animals (cattle, pigs, etc.), depending on the study and product under investigation.

Participation in these studies is always voluntary. To find out more about any individual study, use the contact information provided for that study. Additional information regarding the study and/or the investigational product is considered confidential and may not be disseminated by FDA without express permission of the sponsor.

Sponsors must voluntarily consent to having CVM list their study information on this webpage; therefore, this may not provide a comprehensive list of active or ongoing clinical field studies for ACTPs. The list of studies is updated on this page quarterly.

The studies listed are investigational, and the ACTPs are not FDA approved. This means the safety and effectiveness of the ACTP is not yet determined.

For Developers: CVM Listing of Clinical Field Studies for Animal Cells, Tissues, and Cell- and Tissue-Based Products (ACTPs)

Filters

Study NameSpeciesConditionProduct TypeRecruitment PeriodStudy PeriodCountry or StateContact Information
Single Intra-Articular Administration of Allogeneic Canine Pooled Platelet Lysate for Treatment of Canine OsteoarthritisDog OsteoarthritisCanine allogeneic pooled platelet lysate06/2024-12/202406/2024-01/2026Washingtondrjeffmayo@comcast.net; fizadyar@celltherapytools.com
Phone: 949-630-2050
The use of autologous or allogeneic adipose- or bone marrow-derived mesenchymal stem cells for equine musculoskeletal and nervous diseaseHorseMusculoskeletal diseases; Neurological diseasesAutologous or allogeneic equine adipose or bone marrow-derived mesenchymal stem cells06/2023-12/203306/2023-12/2033New Yorkac2399@cornell.edu
The use of autologous or allogeneic adipose- or bone marrow-derived mesenchymal stem cells for equine keratitisHorseImmune-mediated keratitisAutologous or allogeneic equine adipose- or bone marrow-derived mesenchymal stem cells06/2023-12/203306/2023-12/2033New Yorkkek248@cornell.edu
The use of autologous adipose- or bone marrow-derived mesenchymal stem cells for canine musculoskeletal and nervous diseaseDogMusculoskeletal diseases; Neurologic diseasesAutologous canine adipose- or bone marrow-derived mesenchymal stem cells06/2023-12/203306/2023-12/2033New Yorkcwf37@cornell.edu

The information on this webpage is listed at CVM’s discretion after securing from the sponsor consent to provide publicly their limited study information. At the time of listing, the information is intended for the sole purpose of disclosing legitimate clinical field studies conducted under a file with CVM in support of product development and approval. We are committed to ensuring that all information we publish reflects a level of quality corresponding to the nature and timeliness of the information; and, to disseminate the information as promptly as possible so that the public can benefit from FDA's mission to promote and protect human and animal health.

 



Back to Top